Indrayani Biotech

Indrayani Biotech Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Indrayani Biotech (526445.BO) as of Oct 22, 2026 is 237.94. In the previous year, Cash Conversion Cycle (CCC) was 104.23 — a change of 128.27% (higher).

Cash Conversion Cycle

237.94

YoY

128.27%

Last updated:

Cash Conversion Cycle (CCC) of Indrayani Biotech is 2025 237.94 . Cash Conversion Cycle (CCC) of Indrayani Biotech was 2024 104.23 . It decreases by 128.27% higher compared to the previous year.

The Indrayani Biotech Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2021
31.63 INR
Jan 1, 2022
45.76 INR
Jan 1, 2023
29.56 INR
Jan 1, 2024
104.23 INR
Jan 1, 2025
237.94 INR
The Indrayani Biotech Cash Conversion Cycle history
YEARCash Conversion CycleYoY
237.94+128.27%
104.23+252.59%
29.56-35.39%
45.76+44.66%
31.63—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Indrayani Biotech Stock analysis

What does Indrayani Biotech do? Indrayani Biotech Ltd generates revenue through its diverse operational divisions, with the Food & Hospitality division supplying food services on a contract basis to colleges and universities, hospitals and healthcare institutions, corporate offices, industries, and information technology companies. The Engineering division contributes by offering solutions for design, development, manufacture, maintenance, and services in power electronics. The Healthcare division serves patients through single specialty clinics and hospitals, as well as outsourced single specialty departments within multi-specialty hospitals. Additionally, the Infrastructure division engages in real estate and infrastructure development. The Agri division markets and sells products such as organic milk, edible oil, vermi compost, and panchakavya, while the Biotech division focuses on marketing and selling microorganism-based bio fertilizer and bio control. These combined activities allow the Chennai-based company to serve a wide range of clients across engineering, food supply, healthcare, infrastructure, agriculture, and biotechnology sectors. Indrayani Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Indrayani Biotech stock

Cash Conversion Cycle (CCC) of Indrayani Biotech is 237.94 in 2025.

Cash Conversion Cycle (CCC) of Indrayani Biotech changed from 104.23 to 237.94, representing a 128.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Indrayani Biotech since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Indrayani Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Indrayani Biotech

All Key Metrics — Indrayani Biotech